MARKET

BFRGW

BFRGW

Bullfrog AI Holdings, Inc.
NASDAQ
0.2299
-0.0670
-22.57%
Opening 10:11 04/01 EDT
OPEN
0.2469
PREV CLOSE
0.2969
HIGH
0.2469
LOW
0.1910
VOLUME
27.12K
TURNOVER
--
52 WEEK HIGH
0.8537
52 WEEK LOW
0.1000
MARKET CAP
--
P/E (TTM)
-0.3657
1D
5D
1M
3M
1Y
5Y
1D
BUZZ-U.S. STOCKS ON THE MOVE-Agnico Eagle Mines, ProPetro, Kezar
Reuters · 1d ago
BullFrog AI signs deal with top-5 pharma to identify MDD drug target
Reuters · 2d ago
BULLFROG AI ANNOUNCES COMMERCIAL AGREEMENT WITH TOP 5 GLOBAL PHARMACEUTICAL COMPANY TO IDENTIFY AND PRIORITIZE THERAPEUTIC TARGET IN MAJOR DEPRESSIVE DISORDER
Reuters · 2d ago
Weekly Report: what happened at BFRGW last week (0323-0327)?
Weekly Report · 2d ago
BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive Disorder
Barchart · 2d ago
BullFrog AI hosts bfARENAS webinar with Xtalks Life Sciences; bfARENAS decision engine debuts
Reuters · 03/25 12:19
Weekly Report: what happened at BFRGW last week (0316-0320)?
Weekly Report · 03/23 09:20
Weekly Report: what happened at BFRGW last week (0309-0313)?
Weekly Report · 03/16 09:20
More
About BFRGW
Bullfrog AI Holdings, Inc. is a technology-enabled drug development company. The Company is focused specifically on advanced artificial intelligence / machine learning (AI/ML) analysis of complex data in the advancement of medicine. The Company’s platform technology, bfLEAP, is an analytical AI/ML platform that is a potentially disruptive tool for the analysis of pre-clinical and/or clinical data sets, such as the robust pre-clinical and clinical trial data sets being generated in translational research and development and clinical trial settings. The platform can capture the genetic and physical characteristics of patients in an unbiased manner and contextualize them against other disparate data sources from patients. Its siRNA targets Beta2-spectrin in the treatment of human diseases, such as hepatocellular carcinoma (HCC), obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis. Mebendazole is focused on targeting Glioblastoma.

Webull offers Bullfrog AI Holdings, Inc. stock information, including NASDAQ: BFRGW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BFRGW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BFRGW stock methods without spending real money on the virtual paper trading platform.